NEW YORK STATE COMMON RETIREMENT FUND - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 63 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$1,000
-99.1%
267
-98.9%
0.00%
Q1 2021$117,000
-52.2%
23,400
+20.6%
0.00%
Q4 2020$245,000
+28.3%
19,4000.0%0.00%
Q3 2020$191,000
-1.0%
19,4000.0%0.00%
Q2 2020$193,000
+12.9%
19,4000.0%0.00%
Q1 2020$171,000
-3.9%
19,400
+0.5%
0.00%
Q4 2019$178,000
+26.2%
19,300
-19.6%
0.00%
Q3 2019$141,000
-51.0%
24,0000.0%0.00%
Q2 2019$288,000
-6.2%
24,000
-5.5%
0.00%
Q1 2019$307,000
-3.8%
25,4000.0%0.00%
Q4 2018$319,000
-15.4%
25,4000.0%0.00%
Q3 2018$377,000
-47.6%
25,400
-40.6%
0.00%
-100.0%
Q2 2018$720,000
-4.4%
42,794
+30.1%
0.00%0.0%
Q1 2018$753,000
+20.7%
32,884
+36.3%
0.00%0.0%
Q4 2017$624,000
+161.1%
24,131
+49.0%
0.00%
Q3 2017$239,000
+5.8%
16,2000.0%0.00%
Q2 2017$226,000
-18.1%
16,200
-0.0%
0.00%
Q1 2017$276,000
+65.3%
16,201
+0.0%
0.00%
Q4 2016$167,000
+1.8%
16,2000.0%0.00%
Q3 2016$164,000
-9.9%
16,2000.0%0.00%
Q2 2016$182,000
-17.6%
16,2000.0%0.00%
Q1 2016$221,000
-28.0%
16,2000.0%0.00%
Q4 2015$307,000
+1.0%
16,2000.0%0.00%
Q3 2015$304,000
+128.6%
16,200
+81.2%
0.00%
Q2 2015$133,0008,9400.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
L1 Capital Pty Ltd 1,050,124$10,312,0003.31%
Alambic Investment Management, L.P. 19,934$196,0002.15%
INGALLS & SNYDER LLC 1,363,603$13,391,0000.92%
ACUTA CAPITAL PARTNERS, LLC 300,000$2,946,0000.80%
RA Capital Management 1,858,474$18,250,0000.33%
Perceptive Advisors 2,150,641$21,119,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 310,000$3,044,0000.30%
Eversept Partners, LP 103,829$1,019,6010.23%
Opaleye Management Inc. 100,000$982,0000.19%
GSA CAPITAL PARTNERS LLP 58,095$570,0000.10%
View complete list of CONCERT PHARMACEUTICALS INC shareholders